Demetrix & Bioengineering Rare Cannabinoids | Jeff Ubersax | 14

Send us a text

Nick Jikomes talks to Jeff Ubersax, PhD, CEO of the biotechnology company Demetrix (who supported this episode). Jeff discussed the science behind how Demetrix is engineering baker's yeast to produce cannabinoids at an industrial scale, with a focus on making rare cannabinoids other than THC and CBD.

Jeff also discussed how he transitioned from academic science to running his own company, and offered advice for academic scientists in training who might be thinking about moving into biotechnology.

Episode Support: This episode was supported by Demetrix, a biotechnology company using cutting edge fermentation technology to produce rare cannabinoids that are safe, legal, and effective for health and wellness. 

Support the show

All episodes, show notes, transcripts, etc. at the M&M Substack

Affiliates:

• Lumen device to optimize your metabolism for weight loss or athletic performance. Use code MIND for 10% off.
• Readwise: Organize and share what you read. Use your phone's link.
• Athletic Greens: Comprehensive & convenient daily nutrition. Free 1-year supply of vitamin D with purchase.
• KetoCitra—Ketone body BHB + potassium, calcium & magnesium, formulated with kidney health in mind. Use code MIND20 for 20% off any subscription.
• MASA Chips—delicious tortilla chips made from organic corn and grass-fed beef tallow. No seed oils or artificial ingredients. Use code MIND for 20% off.

For all the ways you can support my efforts